Globus Medical Inc (GMED)
84.91
+1.32
(+1.58%)
USD |
NYSE |
Nov 21, 16:00
85.03
+0.12
(+0.14%)
Pre-Market: 07:52
Globus Medical Revenue (TTM): 2.479B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.479B |
| June 30, 2024 | 2.237B |
| March 31, 2024 | 1.898B |
| December 31, 2023 | 1.568B |
| September 30, 2023 | 1.226B |
| June 30, 2023 | 1.097B |
| March 31, 2023 | 1.069B |
| December 31, 2022 | 1.023B |
| September 30, 2022 | 998.37M |
| June 30, 2022 | 973.94M |
| March 31, 2022 | 961.31M |
| December 31, 2021 | 958.10M |
| September 30, 2021 | 941.53M |
| June 30, 2021 | 927.90M |
| March 31, 2021 | 825.81M |
| December 31, 2020 | 789.04M |
| September 30, 2020 | 767.26M |
| June 30, 2020 | 747.38M |
| March 31, 2020 | 793.00M |
| December 31, 2019 | 785.37M |
| September 30, 2019 | 769.64M |
| June 30, 2019 | 742.66M |
| March 31, 2019 | 721.50M |
| December 31, 2018 | 712.97M |
| September 30, 2018 | 693.06M |
| Date | Value |
|---|---|
| June 30, 2018 | 675.57M |
| March 31, 2018 | 654.58M |
| December 31, 2017 | 635.98M |
| September 30, 2017 | 611.53M |
| June 30, 2017 | 595.44M |
| March 31, 2017 | 580.54M |
| December 31, 2016 | 563.99M |
| September 30, 2016 | 554.99M |
| June 30, 2016 | 556.33M |
| March 31, 2016 | 552.41M |
| December 31, 2015 | 544.75M |
| September 30, 2015 | 530.97M |
| June 30, 2015 | 511.76M |
| March 31, 2015 | 491.76M |
| December 31, 2014 | 474.37M |
| September 30, 2014 | 460.82M |
| June 30, 2014 | 450.22M |
| March 31, 2014 | 443.65M |
| December 31, 2013 | 434.46M |
| September 30, 2013 | 419.75M |
| June 30, 2013 | 407.33M |
| March 31, 2013 | 396.30M |
| December 31, 2012 | 385.99M |
| September 30, 2012 | 373.45M |
| June 30, 2012 | 362.96M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
747.38M
Minimum
Jun 2020
2.479B
Maximum
Sep 2024
1.153B
Average
967.62M
Median
Revenue (TTM) Benchmarks
| Boston Scientific Corp | 15.91B |
| ResMed Inc | 4.807B |
| Haemonetics Corp | 1.361B |
| Abbott Laboratories | 41.22B |
| Stryker Corp | 21.97B |